基于网络药理学和分子对接探讨小青龙汤合人参汤防治高原肺水肿的作用机制
Exploring Mechanism of Xiaoqinglong Combined with Ginseng Decoction in Preventing High Altitude Pulmonary Edema Based on Network Pharmacology and Molecular Docking
DOI: 10.12677/TCM.2023.1212518, PDF,   
作者: 马莉娉, 杨文珂, 王 强, 赵玉荣:青海大学医学部中医系,青海 西宁;马雪曼*:青海省中藏药预防肿瘤重点实验室,青海 西宁
关键词: 高原肺水肿小青龙汤人参汤网络药理学分子对接High Altitude Pulmonary Edema Xiaoqinglong Decoction Ginseng Decoction Network Pharmacology Molecular Docking
摘要: 目的:基于网络药理学和分子对接技术分析小青龙汤合人参汤抗高原肺水肿的作用机制。方法:通过TCMSP获取小青龙汤合人参汤主要活性成分及其靶点;通过OMIM、Genecards和DisGeNET数据库获取高原肺水肿主要作用靶点;通过Venn Diagram得到小青龙汤合人参汤与高原肺水肿的共同靶点;利用String数据库获得数据,用Cytoscape3.9.1建立蛋白质互作(PPI)网络;采用David数据库分析生物过程及信号通路,采用Cytoscape3.9.1软件构建“活性成分–靶点”网络,并运用AutoDock及Pymol对关键靶点与相应活性成分进行分子对接验证。结果:从小青龙汤合人参汤中筛选得到159种活性成分及329个作用靶点,与887个高原肺水肿相关靶点取交集,得到62个共同靶点,GO功能富集分析中生物过程(BP)得到214条,分子功能(MF)得到25条,细胞成分(CC)得到13条;KEGG信号通路富集分析获得93条。结论:小青龙汤和人参汤防治高原肺水肿的核心活性成分为槲皮素、山柰酚、β-谷甾醇等,关键靶点为IL6、TNF、VEGFA等;小青龙汤合人参汤防治高原肺水肿主要涉及HIF-1信号传导途径、脂质和动脉硬化、Toll样受体信号通路、TNF信号传导途径等。
Abstract: Objective: To analyze the mechanism of Xiaoqinglong combined with Ginseng decoction in prevent-ing high-altitude pulmonary edema based on network pharmacology and molecular docking tech-nology. Methods: The main active components and their targets of Xiaoqinglong combined with Ginseng decoction were obtained through the TCMSP, screen the active components of traditional Chinese medicine; obtain the main targets of high altitude pulmonary edema through OMIM, Gene-cards, drugbank databases; obtain the common targets of Xiaoqinglong combined with ginseng de-coction and high altitude pulmonary edema through Venn Diagram; use cytocaspe3.9.1 software to carry out Protein-protein interaction network (PPI) analysis, to construct PPI network; use David database to analyze biological processes and signaling pathways, use Cytoscape3.9.1 software to build an “active ingredient-target” network, and use AutoDock and Pymol performs molecular docking verification on key targets and corresponding active ingredients. Results: 159 active ingre-dients and 329 targets were screened from Xiaoqinglong combined with ginseng decoction, and 887 high-altitude pulmonary edema-related targets were intersected to obtain 62 common targets; in the functional enrichment analysis of GO, 214 biological processes (BP), 25 molecular functions (MF) and 13 cellular components (CC) were obtained. 93 KEGG signal pathways were obtained by en-richment analysis Conclusion Quercetin, kaempferol, β-sitosterol in Xiaoqinglong combined with Ginseng decoction may be the core compounds for treating diseases, and gene targets such as IL6, TNF, and VEGFA are the best target options for diseases. Xiaoqinglong combined with Ginseng de-coction may be involved in the HIF-1 signaling pathway, lipids and atherosclerosis, Toll-like recep-tor signaling pathway, and TNF signaling pathways in treating HAPE.
文章引用:马莉娉, 马雪曼, 杨文珂, 王强, 赵玉荣. 基于网络药理学和分子对接探讨小青龙汤合人参汤防治高原肺水肿的作用机制[J]. 中医学, 2023, 12(12): 3482-3495. https://doi.org/10.12677/TCM.2023.1212518

参考文献

[1] 刘子泉, 崔欢欢, 刘燕青, 郭丽琼, 孟祥艳, 赵艳梅, 柴慈婧, 毕珣, 樊毫军. 高原肺水肿的诊断、治疗与预防[J]. 中华灾害救援医学, 2021, 9(8): 1162-1166. [Google Scholar] [CrossRef
[2] 胡小艳, 汤恩杰. 地塞米松对高原肺水肿大鼠的影响研究[J]. 实用心脑肺血管病杂志, 2017, 25(4): 56-62.
[3] 崔欢欢, 刘子泉, 刘燕青, 马福才, 张德平, 张林林, 侯世科, 樊毫军. 硝苯地平治疗高原肺水肿疗效的系统评价[J]. 武警后勤学院学报(医学版), 2021, 30(4): 72-75. [Google Scholar] [CrossRef
[4] 郑必海, 周先利, 杨清海, 李素芝. 氨茶碱治疗高原肺水肿的机理及其临床应用研究进展[J]. 高原医学杂志, 2005, 15(3): 59-61.
[5] 王小博, 侯娅, 王文祥, 艾小鹏, 胡尧, 陈小睿, 张静, 孟宪丽, 张艺. 藏药红景天的药理作用及其机制研究进展[J]. 中国药房, 2019, 30(6): 851-856.
[6] 石继鹏, 李晓琳, 陈乐乐, 陶文迪, 丁玲, 张继, 李茂星. 蕨麻多糖对大鼠高原脑水肿和肺水肿的保护作用[J]. 国际药学研究杂志, 2020, 47(7): 542-548. [Google Scholar] [CrossRef
[7] 李友伟, 刘蔚红, 刘邦国, 李明春, 刘杨, 苗青, 向卓. 川芎嗪对大鼠低压低氧性肺动脉高压的预防作用及初步机制探讨[J]. 中国药师, 2017, 20(4): 607-611.
[8] 白秀云, 王伟明, 张树明, 白海玉. 人参汤提取物对血管内皮细胞保护作用的研究[J]. 哈尔滨商业大学学报(自然科学版), 2006, 22(3): 11-13.
[9] 钟常英, 李欣宇, 徐慧贤. 基于网络药理学的小青龙汤治疗变应性鼻炎作用机制探讨[J]. 世界中医药, 2021, 16(22): 3310-3315.
[10] 王成, 刘磊, 张传涛, 曾珠, 董朝强, 黄青松. 小青龙汤治疗慢性支气管炎疗效及机制研究概况[J]. 中医药临床杂志, 2020, 32(6): 1186-1189. [Google Scholar] [CrossRef
[11] 曾晓华. 小青龙汤合三子养亲汤对表寒里饮型COPD患者FeNO及血清细胞因子水平的影响[J]. 医学理论与实践, 2023, 36(20): 3468-3470. [Google Scholar] [CrossRef
[12] 解静, 高杉, 李琳, 徐一兰, 高树明, 于春泉. 网络药理学在中药领域中的研究进展与应用策略[J]. 中草药, 2019, 50(10): 2257-2265.
[13] 任宇哲, 万军, 于宙, 等. 基于糖皮质激素受体介导TGF-β1/Smad3信号轴探讨小青龙汤加减合二陈汤治疗咳嗽变异性哮喘的药效及机制[J]. 中医药导报, 2021, 27(8): 10-14.
[14] 常彩虹, 吴河山, 高玉林, 王敏, 张丹. 小青龙汤联合信必可都保治疗支气管哮喘的临床疗效及对炎症因子、气道重塑和免疫功能的影响[J]. 中药材, 2021, 44(5): 1249-1253. [Google Scholar] [CrossRef
[15] 李兆钰, 王永成, 周国锋, 等. 小青龙汤治疗寒痰阻肺型慢性心力衰竭的临床疗效及作用机制[J]. 中国实验方剂学杂志, 2021, 27(1): 17-22. [Google Scholar] [CrossRef
[16] Hopkins, A.L. (2008) Network Pharmacology: The Next Paradigm in Drug Discovery. Nature Chemical Biology, 4, 682-690. [Google Scholar] [CrossRef] [PubMed]
[17] Zhang, R.Z., Yu, S.J., Bai, H. and Ning, K. (2017) TCM-Mesh: The Database and Analytical System for Network Pharmacology Analysis for TCM Preparations. Scientific Reports, 7, Arti-cle No. 2821. [Google Scholar] [CrossRef] [PubMed]
[18] Ru, J.L., Li, P., Wang, J.N., Zhou, W., Li, B.H., Huang, C., Li, P.D., Guo, Z.H., Tao, W.Y., Yang, Y.F., Xu, X., Li, Y., Wang, Y.H. and Yang, L. (2014) TCMSP: A Database of Sys-tems Pharmacology for Drug Discovery from Herbal Medicines. Journal of Cheminformatics, 6, Article No. 13. [Google Scholar] [CrossRef] [PubMed]
[19] Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. and Morishima, K. (2017) KEGG: New Perspectives on Genomes, Pathways, Diseases and Drugs. Nucleic Acids Research, 45, 353-361. [Google Scholar] [CrossRef] [PubMed]
[20] Trott, O. and Olson, A.J. (2010) AutoDock Vina: Improving the Speed and Accuracy of Docking with a New Scoring Function, Efficient Optimization, and Multithreading. Journal of Compu-tational Chemistry, 31, 455-461. [Google Scholar] [CrossRef] [PubMed]
[21] Luo, Y., Yang, X. and Gao, Y. (2013) Strategies for the Prevention of Acute Mountain Sickness and Treatment for Large Groups Making a Rapid Ascent in China. International Journal of Cardiol-ogy, 169, 97-100. [Google Scholar] [CrossRef] [PubMed]
[22] Tripathi, A., Kumar, M., Kaur, P., Kumar, B. and Sagi, S.S.K. (2020) Efficacy of Quercetin as a Potent Sensitizer of β 2-AR in Combating the Impairment of Fluid Clearance in Lungs of Rats under Hypoxia. Respiratory Physiology & Neurobiology, 273, Article ID: 103334. [Google Scholar] [CrossRef] [PubMed]
[23] Tripathi, A., Hazari, P.P., Mishra, A.K., Kumar, B. and Sagi, S.S.K. (2021) Quercetin: A Savior of Alveolar Barrier Integrity under Hypoxic Microenvironment. Tissue Barriers, 9, Article ID: 1883963. [Google Scholar] [CrossRef] [PubMed]
[24] 付成瑞. 山奈酚对小鼠放射性肺损伤防治作用的实验研究[D]: [硕士学位论文]. 济南: 济南大学, 2014.
[25] 赵妍. 山奈酚对脂多糖诱导小鼠急性肺损伤的保护作用[D]: [硕士学位论文]. 哈尔滨: 东北农业大学, 2013.
[26] 曹丽睿, 查玉杰, 何庆. 山柰酚对大鼠高原肺水肿的预防作用及机制研究[J]. 天津医科大学学报, 2022, 28(1): 58-64
[27] 姚凤, 周清燕, 熊瑛, 关爽. β-谷甾醇对脂多糖诱导的小鼠急性肺损伤的保护作用研究[J]. 中国农学通报, 2015, 31(2): 55-61.
[28] 周强, 张坤, 李富强, 刘伟, 王鑫. β-谷甾醇缓解LPS诱导的急性肺损伤大鼠炎症反应和纤维化[J]. 西部医学, 2022, 34(6): 813-818.
[29] 吴力超, 李俊峰, 张婷婷, 陶方方, 刘文洪. 基于网络药理学和细胞实验探讨豆甾醇抗炎作用[J]. 中成药, 2022, 44(2): 609-615
[30] 陈雪, 石亚琳, 孙合圣, 李海艳, 宋延刚. 基于Notch信号通路探讨柚皮素调节Th17/Treg平衡治疗哮喘的机制研究[J]. 中国免疫学杂志, 2023, 39(7): 1383-1389
[31] 张迪, 张冬梅, 陆瑞敏, 吉静, 许宗颖, 王旭, 陈萌. 基于“肺主行水”理论探究小青龙汤调节肺水转运蛋白的作用机制[J]. 中国实验方剂学杂志, 2022, 28(8): 1-11. [Google Scholar] [CrossRef
[32] Savale, L., Tu, L., Rideau, D., Izziki, M., Maitre, B., Adnot, S., et al. (2009) Impact of Interleukin-6 on Hypoxia-In- duced Pulmonary Hypertension and Lung Inflammation in Mice. Respiratory Research, 10, Article No. 6. [Google Scholar] [CrossRef] [PubMed]
[33] Song, S., Choi, K., Ryu, S.W., Kang, S.W. and Choi, C. (2011) TRAIL Promotes Caspase-Dependent Pro-Inflammatory Responses via PKCδ Activation by Vascular Smooth Muscle Cells. Cell Death & Disease, 2, e223. [Google Scholar] [CrossRef] [PubMed]
[34] Ye, Y., Xu, Q. and Wuren, T. (2023) Inflammation and Immunity in the Pathogenesis of Hypoxic Pulmonary Hypertension. Frontiers in Immunology, 14, Article 1162556. [Google Scholar] [CrossRef] [PubMed]
[35] Liu, Y., Zhang, H., Yan, L., Du, W., Zhang, M., Chen, H., et al. (2018) MMP-2 and MMP-9 Contribute to the Angiogenic Effect Produced by Hypoxia/15-HETE in Pulmonary Endo-thelial Cells. Journal of Molecular and Cellular Cardiology, 121, 36-50. [Google Scholar] [CrossRef] [PubMed]
[36] 帅鹏, 陈浩, 陈露. 急性高原肺水肿血浆TNF_(-α)、IL_(-6)、ET_(-1)的变化及临床意义[J]. 西藏科技, 2004(4): 40-41, 45.
[37] 吴刚, 高文祥, 高钰琪. HIF-1: 高原肺水肿防治的新靶点[J]. 中国高原医学与生物学杂志, 2020, 41(1): 8-10, 16. [Google Scholar] [CrossRef